Could HLA-DR B1*11 allele be a clue for predicting extrapulmonary sarcoidosis?

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 31, Issue 2, 2014, Pages 154-162

  Ozyilmaz, Ezgi ^a   Ozturk, Ozlem Goruroglu ^a   Yunsel, Dilek ^a   Deniz, Ali ^a   Hanta, Ismail ^a   Kuleci, Sedat ^a   Seydaoglu, Gulsah ^a   Erken, Eren ^a   Kocabas, Ali ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Extra pulmonary involvement; HLA DR alleles; Sarcoidosis

Indexed keywords

DNA; HLA DRB1 01 ANTIGEN; HLA DRB1 03 ANTIGEN; HLA DRB1 04 ANTIGEN; HLA DRB1 07 ANTIGEN; HLA DRB1 08 ANTIGEN; HLA DRB1 09 ANTIGEN; HLA DRB1 10 ANTIGEN; HLA DRB1 11 ANTIGEN; HLA DRB1 12 ANTIGEN; HLA DRB1 13 ANTIGEN; HLA DRB1 14 ANTIGEN; HLA DRB1 15 ANTIGEN; HLA DRB1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; COUGHING; DYSPNEA; EXTRA PULMONARY SARCOIDOSIS; FATIGUE; FEMALE; FEVER; FOLLOW UP; GENETIC ANALYSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERCALCEMIA; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALAISE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; RISK FACTOR; SMOKING; SPUTUM PRODUCTION; THORAX PAIN; TURK (PEOPLE); TURKEY (REPUBLIC); VERY ELDERLY; WEIGHT REDUCTION; CASE CONTROL STUDY; CAUCASIAN; EPIDEMIOLOGY; ETHNOLOGY; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; IMMUNOLOGY; MIDDLE AGED; ODDS RATIO; PHENOTYPE; PROTECTION; RISK ASSESSMENT; SARCOIDOSIS; STATISTICAL MODEL; TURKEY;

ADULT; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DRB1 CHAINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; SARCOIDOSIS; TURKEY;

EID: 84907313803     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society(ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999; 160: 736-55.
2. Judson MA. Extrapulmonary sarcoidosis. Semin Respir Crit Care Med 2007; 28: 83-101
3. Baughman RP, Teirstein AS, Judson MA, et al. A Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001; 164(10 Pt 1): 1885-9.
4. Sato H, Woodhead FA, Ahmad T, et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet. 2010; 19: 4100-11.
5. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess hepler T-lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305: 429-34
6. Gerke AK, Hunninghake G. The immunology of sarcoidosis. Clin Chest Med 2008; 29: 379-90
7. Iannuzzi MC, Fontana JR. Sarcoidosis: Clinical presentation, immunopathogenesis, and therapeutics. JAMA 2011; 305: 391-9
8. Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 2011; 183: 573-81.
9. Campbell RD, Trowsdale J.Map of the human MHC. Immunol Today 1993; 14: 349-352.
10. Schürmann M, Reichel P, Müller-Myhsok B, Schlaak M, Müller-Quernheim J, Scwinger E. Results from a genome wide search for predisposing genes in sarcoidosis. Am j Respir Crit Care Med 2001; 164: 840-6
11. Celik G, Sen E, Ulger AF, et al. Human leukocyte antigens A and B in Turkish patients with sarcoidosis. Arch Bronconeumol 2004; 40: 449-52
12. BilirM, Sipahi S, Yilmaz E, et al. Analysis of HLA antigens in Turkish sarcoidosis patients. Southern Med J 2007; 100: 356-9
13. Rossman MD, Thompson B, Frederick M, et al. ACCESS Group.HLA- DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet. 2003; 73: 720-35.
14. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997; 156: 1601-5
15. Rossman MD, Thompson B, Frederick M, et al. and the ACCESS Group. HLA and environmental interactions in sarcoidosis. Sarcoid Vasc Diffuse Lung Dis 2008; 25: 125-32
16. Voorter CE, Drent M, Hoitsma E, Faber KG, van den Berg-Loonen EM. Association of HLA DQB1 0602 in sarcoidosis patients with small fiber neuropathy. Sarcoidosis Vasc Diffuse Lung Dis. 2005; 22: 129-32.
17. Sato H, Nagai S, du Bois RM, et al. HLA-DQB1*0602 allele is associated with splenomegaly in Japanese sarcoidosis. J Intern Med 2007; 262: 449-57
18. Naruse TK, Matsuzawa Y, Ota M, et al. HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens 2000; 56: 52-57
19. Grubic Z, Zunec R, Peros-Golubicic T, et al. HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLAB8, -DRB1*0301, and -DQB1*0201 haplotype in clinical variations of the disease. Tissue Antigens. 2007; 70: 301-6.
20. Mrazek F, Holla LI, Hutyrova B, et al. Association of tumour necrosis factor-Alpha,lymphotoxin-Alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens. 2005; 65: 163-71.
21. Grunewald J, Eklund A. Lofgren's syndrome: Human Leukocyte Antigen strongly influences the disease course.Am J Respir Crit Care Med 2009; 179: 307-12
22. Darlington P,Tallstedt L, Padyukov L, et al.HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis. Eur Respir J 2011; 38: 1151-1157
23. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilator flows. Report of the Working Party on Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40.
24. Storey JD: A direct approach to false discovery rates. J R Statist Soc B 2002, 64: 479-498
25. Sverrild A, Backer V, Kyvik KO, et al. Heredity in sarcoidosis: a registry based twin study. Thorax 2008; 63: 894-6
26. Rybicki BA, Kirkey KL, Major M, et al. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 2001; 153: 188-93
27. Rybicki BA, Iannuzzi MC, Frederick MM, et al. ACCESS Research Group. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001; 164: 2085-91.
28. Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarc Vasc Diffuse Lung Dis 2012; 29: 119-27
29. Spagnolo P, Grunewald J. Recent advances in the genetics of sarcoidosis. J Med Genet 2013; 50: 290-7
30. Grunewald J. Review: Role of genetics in susceptibility and outcome of sarcoidosis. Semin Respir Crit Care Med 2010; 31: 380-9
31. Mangalam AK, Taneja V, David CS. HLA class II molecules influence susceptibility versus protection in inflammatory diseases by determining the cytokine profile. J Immunol. 2013; 190: 513-8.
32. Dubaniewicz A, Dubaniewicz A, Dubaniewicz-Wybieralska M, Moszkowska G, Sternau A, Dubaniewicz A. Comparative analysis of DR and DQ alleles occurrence in sarcoidosis and tuberculosis in the same ethnic group: preliminary study. Sarcoidosis Vasc Diffuse Lung Dis. 2006; 23: 180-9.
33. Zhou Y, Shen L, Zhang Y, Jiang D, Li H.Human leukocyte antigen-A, -B, and -DRB1 alleles and sarcoidosis in Chinese Han subjects. Human Immunol 2011; 72: 571-5
34. Grunewald J, Brynedal B, Darlington P, et al. Different HLA-DRB1 allele distrubutions in distinct clinical subgroups of sarcoidosis patients. Respir Res 2010; 11: 25
35. Wennerström A, Pietinalho A, Vauhkonen H, et al. HLA-DRB1 allele frequencies and C4 copy number variation in Finnish sarcoidosis patients and associations with disease prognosis. Human Immunol 2012; 73: 93-100
36. Sharma SK, Balamurugan A, Pandey RM, Saha PK,Mehra NK.Human Leukocyte Antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am J Respir Cell Mol Biol 2003; 29: 225-31
37. Okumus G, Musellim B, Cetinkaya E, et al. Extrapulmonary involvement in patients with sarcoidosis in Turkey. Respirology 2011; 16: 446-50
38. Invernizzi P, Selmi C, Poli F, et al. Human Lekocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls.Hepatology 2008; 48: 1906-12
39. Deschamps R, Paturel L, Jeannnin S, et al. Different HLA Class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among French Afro-Caribbean population.Multiple Sclerosis Journal 2011; 17: 24-31
40. Marangon AV, Silva GF, de Moraes CFV, et al. Protective effect of HLA-DRB1*11 and predisposition of HLA-C.04 in the development of severe liver damage in Brazilian patients with chronic hepatitis C virus infection. Scandinavian J Immunol 2012; 76: 440-7
41. Mokni-Baizig N, Ayed K, Ayed FB, et al. Association between HLA-A/-B antigens and DRB1 alleles and nasopharyngeal carcinoma in Tunisia. Oncology 2001; 61: 55-8
42. Foley PJ,McGrath DS, Puscinska E, et al.Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Biol. 2001; 25: 272-7
43. Müller-Quernheim J, Schürmann M, Hofmann S, et al. Genetics of sarcoidosis. Clin Chest Med. 2008; 29: 391-414,
44. Voorter CE, Amicosante M, Berretta F, Groeneveld L, Drent M, van den Berg-Loonen EM. HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens. 2007; 70: 18-27.
45. Judson MA. A proposed solution to the clinical assessment of sarcoidosis: the sarcoidosis three-dimensional assessment instrument (STAI).Med Hypotheses 2007; 68: 1080-7.
46. Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med 2003; 167: 1225-31.